Drug Trial Radar · NCT06728176
Safety and PK of Multiple Doses of MT1988
Last checked: Nov 19, 2026Latest source record: Apr 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Nov 25, 2024
Primary completion
Apr 8, 2025
Study completion Apr 10, 2025
Sponsor
- Lead sponsor
- Monument Therapeutics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Dec 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to assess the tolerability and amount of drug in the blood when four dose levels of MT1988 are administered for 14 days to healthy volunteers. The main question it aims to answer is: * what side effects are seen while administering MT1988 for 14 days? * how much of MT1988 can be measured in the blood at the beginning and end of administering MT1988 for 14 days? Researchers will include a placebo arm (dummy drug) to compare the side effects. Participants will: * take MT1988 every day for 14 days * visit the clinic once per week for assessments * keep a diary to record information between clinic appointments.
Conditions
- Healthy Volunteer
Interventions
MT1988Drug
Active Drug
PlaceboDrug
Placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse eventsTime frame: From Day 1 to end of follow up (Day 21-28)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
BDD Pharma Ltd
Glasgow, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.